Data-Driven Decisions in Crohn's Disease: Positioning Patients for Success

While there is a tendency for clinicians to rely on one approach to treating Crohn's disease (CD), making confident data-driven treatment decisions in moderate-to-severe CD is imperative for durable, long-term remission. The traditional approach that has been based on progressive, step-wise treatment intensification with re-evaluation of response according to symptoms does not improve long-term outcomes in CD and increases risk for bowel damage. However, the introduction of treat-to-target (T2T) management strategies and the integration of novel therapies targeting new pathways supported by long-term efficacy and safety data have resulted in a paradigm shift in CD treatment.

This unique symposium will harness the experience, evidence, and expertise of team leaders in the management of CD to offer new insights and strategies to optimize treatment positioning. A patient case will serve as the foundation and springboard for solving complex clinical conundrums of patients with CD seen daily in practice.

Learning Objectives
At the end of this CME/CE activity, participants should be able to:
» Incorporate individual disease characteristics into treatment decisions in CD based on evidence-based recommendations.
Differentiate biologic therapies in CD based on efficacy and long-term safety to achieve a rapid and durable treatment response.
Develop a data-driven treatment algorithm for CD to position treatment choices based on efficacy, safety, and patient characteristics.